Skip to main content

Funding

The Australasian Society of Clinical Immunology and Allergy (ASCIA) and Allergy & Anaphylaxis Australia (A&AA), as the leading medical and patient support organisations for allergy in Australia, developed the first National Allergy Strategy for Australia, in collaboration with other stakeholder organisations. ASCIA and A&AA greatly appreciate the funding support that has enabled the development and initial implementation of the National Allergy Strategy.

In 2022, The National Allergy Council was established as a formalisation of the partnership between ASCIA and A&AA, and the National Allergy Council continues to implement the National Allergy Strategy alongside ASCIA and A&AA.

The National Allergy Council has received funding from the Australian Government Department of Health, Disability & Ageing to progress the implementation of the National Allergy Strategy in response to the Parliamentary Inquiry into Allergies and Anaphylaxis which led to the Walking the allergy tightrope report. This funding also includes funding provision for the National Allergy Council partner organisations - ASCIA and A&AA.

The Australian Government's response to the Walking the allergy tightrope report was tabled in Parliament in April 2023.

For more information about the project work being undertaken by the National Allergy Council, visit our project webpages.

Development of the National Allergy Strategy

While funding from the Australian Government Department of Health, Disability & Ageing has supported implementation since 2015, development of the National Allergy Strategy, including two Allergy Summits was funded by unrestricted education grants obtained by ASCIA. These grants were from the following organisations:

Major supporters:

  • Mylan (formerly Alphapharm)
  • Seqirus (formerly bioCSL)
  • Stallergenes Greer
  • Bayer

Other supporters:

  • Nutricia
  • Nestlé Nutrition
  • Merck Sharp & Dohme

It is important to note that the content of both the Allergy Summits and the National Allergy Strategy has been independently developed and has not been influenced by organisations that have provided unrestricted educational grants.

Implementation of the National Allergy Strategy

Government funding

  • Australian Government Department of Health, Disability & Ageing
  • Australian Digital Health Agency

Unrestricted education grants

Prior to 2021, the following organisations provided unrestricted education grants to help implement the National Allergy Strategy projects:

Major supporters:

  • PCH Foundation
  • GSK
  • Mylan
  • Sanofi
  • Abbott
  • Allergy Concepts
  • Nutricia
  • Bayer

Other supporters:

  • DBV Technologies
  • Stallergenes Greer
  • Abacus dx
  • Nestle Nutrition

It is important to note that the implementation of the National Allergy Strategy has not been influenced by organisations that have provided unrestricted educational grants.

Private donations

  • The National Allergy Strategy has received private donations from families and ASCIA members to help implement the National Allergy Strategy.

Content updated July 2025